This page compares what is documented about Survodutide and Tirzepatide, rather than ranking them by effect. What each molecule is, the sizes and prices actually carried, what the certificate covers, and how the two differ on the bench. Everything here is research-use-only material and we do not publish outcome, dosing or administration content for any compound in the catalogue.
What is Survodutide and what is Tirzepatide?
Survodutide. Survodutide is a dual GLP-1 and glucagon receptor agonist, one of several multi-receptor candidates that have expanded the incretin literature since 2022.
Tirzepatide. Tirzepatide is the reference dual GIP/GLP-1 receptor agonist in the literature, and it anchors much of the comparative work newer incretin analogues are measured against.
How do Survodutide and Tirzepatide compare on price and size?
| Survodutide | Tirzepatide | |
|---|---|---|
| Sizes carried | 10 mg | 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg, 80 mg, 90 mg, 100 mg, 110 mg, 120 mg |
| From | $160.00 | $50.00 |
| Best price per unit | $16.00 / mg | $2.17 / mg |
| Availability | Backordered — waitlist | Backordered — waitlist |
| Certificate | Lot certificate on the product page | Lot certificate on the product page |
| Molecular formula | C192H289N47O61 | C225H348N48O68 |
| Molar mass | 4,232 g/mol | 4,813 g/mol |
| Source | PubChem CID 171378821 | PubChem CID 166567236 |
| Research area | incretin receptor pharmacology | GIP/GLP-1 receptor research |
At their best sizes Tirzepatide works out at $2.17 per mg against $16.00 for Survodutide — 7.4 times more for the mg. Vial prices start at $160.00 and $50.00 respectively, which is the number most people compare and the one that says least, because the two are not sold in the same sizes. Full sizes, tier pricing and the lot certificate sit on the Survodutide page and the Tirzepatide page.
What is each one studied for?
What the published literature investigates, which is a different question from what either will do, and the only one of the two a supplier can answer.
Survodutide is studied in incretin receptor pharmacology research. Multi-receptor incretin pharmacology is currently among the most active areas in metabolic research.
Tirzepatide is studied in gip/glp-1 receptor research. Dual-agonist incretin research keeps expanding, and tirzepatide remains the benchmark compound most new metabolic work is compared against.
Studied in the same area does not make two compounds interchangeable, and the research library holds the per-compound documentation.
Tirzepatide vs Survodutide: how they differ on the bench
Tirzepatide. Our tirzepatide storage guide is one of the most-read pages on the site: sealed powder archives cold and dark, and prepared solutions get dated the day they are made.
Survodutide. Multi-receptor peptides are long enough that identity confirmation by mass alone is weak evidence; sequence-level confirmation is the standard worth asking for.
What actually differs between Tirzepatide and Survodutide
Worth doing the arithmetic before comparing sizes: Tirzepatide is 4,813 g/mol and Survodutide is 4,232 g/mol, a factor of 1.1. A milligram of Survodutide therefore contains roughly 1.1 times as many molecules as a milligram of Tirzepatide, so two vials of the same labelled mass hold quite different amounts of substance. Equal milligrams are not equal moles, which is what the molarity calculator exists to convert, and it is the reason a price-per-milligram comparison and a price-per-mole comparison can point at different vials.
Identity is the other analytical axis, and it is settled per lot rather than per compound. Tirzepatide. Catalogued as Tirzepatide, and the certificate's identity test resolves to that.
Both are released against a certificate reporting identity, purity by the stated method and net peptide content, readable before anything is bought.
Which is better, Tirzepatide or Survodutide?
Neither Tirzepatide nor Survodutide is ranked against the other here, and the refusal is deliberate. Better, safer and stronger are questions about effects in a living system, and we sell neither compound for use in one — why none of these pages ranks two compounds sets out the reasoning in full.
What it does instead, for these two:
- Tirzepatide is the cheaper of the two per mg, at $2.17 against $16.00.
- Tirzepatide is the heavier molecule by a factor of 1.1, so equal milligrams are not equal moles.
- Survodutide is carried in 1 size and Tirzepatide in 14, and each lot carries its own certificate.
Every one of those is checkable before you buy.
Common questions
What is the difference between Tirzepatide and Survodutide?
Different molecules before anything else: Tirzepatide is C225H348N48O68 and Survodutide is C192H289N47O61. Tirzepatide is the reference dual GIP/GLP-1 receptor agonist in the literature, and it anchors much of the comparative work newer incretin analogues are measured against. Survodutide is a dual GLP-1 and glucagon receptor agonist, one of several multi-receptor candidates that have expanded the incretin literature since 2022.
Which one should I choose?
Survodutide is carried in 10 mg and Tirzepatide in 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg, 80 mg, 90 mg, 100 mg, 110 mg, 120 mg, each lot with its own certificate. Which of those suits the work is yours to decide; everything here is research-use-only rather than guidance for use in a human or an animal.
Do both Survodutide and Tirzepatide come with a certificate of analysis?
Neither is in stock at the moment, so in each case the certificate is the one attached to the lot that arrives. A certificate belongs to a lot, not to a product. It is linked from the product page, and reports identity, purity by the stated method, and net peptide content for the material actually in that lot.
Which is cheaper, Tirzepatide or Survodutide?
Per mg, Tirzepatide at $2.17 against $16.00, taking each one's best size. By vial they start at $160.00 for Survodutide and $50.00 for Tirzepatide, which is the comparison most people make and the one that says least, because the two are not sold in the same sizes.
Is a milligram of Survodutide the same as a milligram of Tirzepatide?
By mass yes, by amount of substance no. Tirzepatide is 4,813 g/mol and Survodutide is 4,232 g/mol, a factor of 1.1, so a milligram of Survodutide holds roughly 1.1 times as many molecules. Two vials with the same number on the label are not the same amount of substance, which is what the molarity calculator converts.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.